How to pick a stock: 5 essential steps for beginners
Found a stock to buy? Follow these five steps before making an investment.
MPs pressure London Stock Exchange over Chinese fast fashion giant’s £50bn listing
The London Stock Exchange (LSE) is under pressure to closely vet Chinese fast fashion giant Shein ahead of its planned £50bn listing, amid fears about forced labour in its supply chain.
Constellation Stock Is Having a Great—and Terrible—Friday
Constellation stock is up! No, it’s down! Wait, who’s right? Turns out, they both are.
Why Is Intellia Therapeutics Stock Trading Lower On Friday?
On Thursday, Intellia Therapeutics Inc (NASDAQ:NTLA) outlined its strategic priorities for 2025, emphasizing the acceleration of late-stage programs for NTLA-2002 and nex-z. These therapies target hereditary angioedema (HAE) and transthyretin (ATTR) amyloidosis, respectively. Intellia prioritized NTLA-2002 and nex-z while discontinuing the NTLA-3001 program and other early-stage initiatives. The reorganization will result in a 27% workforce reduction and a projected $8 million restructuring char
Wall Street 'fear gauge' at 3-week high as stocks sink
Wall Street's most watched gauge of investor anxiety rose to a three-week high on Friday as stock indexes sold off following a an upbeat jobs report that pushed back market expectations for further Federal Reserve interest rate cuts. The Cboe Volatility Index - an options-based indicator that reflects demand for protection against drops in the stock market - was last up 1.1 points to 19.18. A reading of 20 or higher on the VIX is associated with robust demand for options protection.
Cathie Wood sells $17 million of tumbling tech stock
The Nasdaq Composite has gained 34.1% in the past 12 months, while Ark Innovation ETF returned 19.1%.
Travelers Are Buying Into Delta's 'Premium' Push—And the Airline's Stock Is Rising
Delta Air Lines bills itself as the "premium" U.S. airline. Passengers appear to be buying in.
Why Is Cancer-Focused Mersana Therapeutics Stock Trading Lower On Friday?
On Friday, Mersana Therapeutics Inc. (NASDAQ:MRSN) released initial data from the Phase 1 dose escalation and backfill cohorts for emiltatug ledadotin. Emi-Le was generally well tolerated, with no Grade 4 or 5 treatment-related adverse events reported. At intermediate doses in the trial (38.1 mg/m2 to 67.4 mg/m2), the confirmed objective response rate among evaluable patients was 23% (6 of 26 patients) across all B7-H4 high tumors and 23% (3 of 13 patients) with B7-H4 high TNBC, all of whom had
Modelo Beer Maker Constellation Brands’ Stock Plummets on Lowered Growth Forecast
Constellation Brands shares plunged Friday, after the maker of beer, wine, and spirits cut its guidance as consumers held back spending.
WBA soars: Walgreens stock up 25% on earnings despite store closures, as investors hope the worst is over
The long-struggling chain reported better-than-expected revenue for its Q1 2025, although operating losses grew as it plans to shutter over a thousand locations.